Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance

Timing of Second Generation ALK Inhibitors: First Line vs. Treatment after Acquired Resistance

From: GRACEcast
0 0 4 years ago
Dr. Ross Camidge, University of Colorado, addresses the question of whether to use a second generation ALK inhibitor as first line therapy or only after acquired resistance to crizotinib.

Find us on Facebook